Back to mobile site

RBC Capital Downgrades Spruce Biosciences, Inc. (SPRB) to Sector Perform, 'Trial Miss Puts Tilda’ Future in Flux'

March 13, 2024 9:50 PM EDT Send to a Friend
(Updated - March 14, 2024 4:33 AM EDT)

RBC Capital analyst Gregory Renza downgraded Spruce Biosciences, Inc. (NASDAQ: SPRB) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login